Inhibition of nonhomologous end joining-mediated DNA repair enhances anti-HBV CRISPR therapy.
Murai K, Kodama T, Hikita H, Shimoda A, Fukuoka M, Fukutomi K, Shigeno S, Shiode Y, Motooka D, Higuchi Y, Miyakawa K, Suemizu H, Ryo A, Tahata Y, Makino Y, Yamada R, Sakamori R, Tatsumi T, Takehara T.
Murai K, et al. Among authors: makino y.
Hepatol Commun. 2022 Sep;6(9):2474-2487. doi: 10.1002/hep4.2014. Epub 2022 May 24.
Hepatol Commun. 2022.
PMID: 35608131
Free PMC article.